Tenet Healthcare (NYSE:THC) Director Sells $532,050.00 in Stock

Tenet Healthcare Corporation (NYSE:THC) Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock traded down $7.61 during midday trading on Thursday, hitting $173.45. The company had a trading volume of 1,121,464 shares, compared to its average volume of 1,578,558. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21. The stock has a market cap of $14.94 billion, a PE ratio of 9.02, a P/E/G ratio of 1.19 and a beta of 1.30. The business’s 50 day simple moving average is $190.50 and its two-hundred day simple moving average is $202.06. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same quarter last year, the firm earned $4.36 EPS. Tenet Healthcare’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities analysts predict that Tenet Healthcare Corporation will post 17.67 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on THC. Jefferies Financial Group lifted their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. UBS Group boosted their price target on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Tenet Healthcare in a research note on Friday, March 27th. Truist Financial boosted their price target on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $244.16.

Institutional Investors Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the company. WCM Investment Management LLC grew its stake in Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after acquiring an additional 362,083 shares during the period. AlphaQuest LLC grew its stake in Tenet Healthcare by 238.3% in the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock valued at $1,211,000 after acquiring an additional 4,202 shares during the period. Winnow Wealth LLC acquired a new position in Tenet Healthcare in the third quarter valued at about $1,129,000. Savant Capital LLC boosted its position in shares of Tenet Healthcare by 27.5% during the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after buying an additional 3,647 shares during the period. Finally, Caption Management LLC acquired a new position in shares of Tenet Healthcare during the third quarter worth about $5,650,000. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.